Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Bonus Payments Awarded To Cook’s Stent, Second Sight’s Eye Implant

Executive Summary

Cook Medical’s Zilver PTX stent and Second Sight Medical Products’ Argus II retinal prosthesis system will enjoy new-technology add-on payments in 2014 under CMS’ hospital inpatient prospective payment system final rule.

You may also be interested in...



Eye Disorders Are Focus Of Novel Neurostimulation Technologies

Neurostimulation technology is migrating into the ophthalmology field, and the implications could be significant for the millions of patients worldwide with degenerative eye diseases, including retinitis pigmentosa and age-related macular degeneration, as well as those with moderate-to-severe dry eye disease. Companies active in this space include Second Sight Medical Products, Retina Implant AG, Pixium Vision, Nano Retina, and many others.

Cook Recalls Zilver Drug-Eluting Stent Due To Catheter Separation Issue

Cook Medical has stopped shipments and initiated a global recall of its Zilver PTX drug-eluting stent due to reports of the device’s delivery system separating at the tip of the inner catheter.

Neuromodulation Market: Innovation Brings High-Growth Rewards

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT035673

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel